NewsCLINICALTRIALS.GOVTuesday, March 3, 2026 · March 3, 2026
New recruiting trial: Assessing the Impact of Intensification of Lipid Lowering Therapy With Guidelines-based Evinacumab Administration on Coronary Plaque Volumes Measured by Coronary Computed Tomography Angiography (CCTA) in Patients With Homozygous Familial Hypercholesterolemia (HoFH)
WHY IT MATTERS
New clinical trials expand access to investigational treatments for rare disease patients.
This observational, multicenter, retrospective and prospective study aims to evaluate the impact of intensified lipid-lowering therapy including Evinacumab on coronary atherosclerotic plaque burden in patients with Homozygous Familial Hypercholesterolemia (HoFH). HoFH is a rare genetic disorder cha
Clinical TrialRecruitingHomozygous Familial Hypercholesterolemia (HoFH)Coronary Computed Tomography Angiography
Related news
ClinicalTrials.gov · April 14, 2026
New recruiting trial: Evaluation of Socio-professional Inclusion for Young Adults Aged 15-25 Living With a Rare Genetic Disability
Rare diseases are often synonymous with difficulties for sufferers, whether physical, mental or social. Patients sufferi…
ClinicalTrials.gov · April 13, 2026
New recruiting trial: Study of High-Precision Evaluation of Molecular ResiduaL Disease Through a PlatfOrm for Cancer TracKing and Interception (SHERLOCK)
This study will collect, annotate, and sequence biospecimens (blood, tissue, urine, saliva and surgery drainage) from pa…
ClinicalTrials.gov · February 20, 2026
New recruiting trial: FACE.S-4-KIDS : A Deep Phenotyping Database of Craniofacial Anomalies During Development With 4 Pilot Projects
FACE.S-4-KIDS is an ambitious database project addressing the scientific question of the variable expression of craniofa…
ClinicalTrials.gov · February 5, 2026
New recruiting trial: Genetic Aortic Diseases and Cardiovascular Complications. An Observational Survey of Risk Factors.
The aim of this observational study is to define the behavioural and cardiovascular risk factor profiles of patients wit…